Ciclesonide is a corticosteroid currently approved in Europe for the treatment of inflammation that is the critical source of asthma symptoms. Data were recently presented at US conferences discussing ...

Learn everything you need to know about Ciclesonide-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

With the COVID-19 pandemic, the world has suffered hundreds of thousands of deaths and tens of millions of cases. In order to contain this outbreak, new and already approved drugs are being tested. A ...

Sunovion Pharmaceuticals Inc. (Sunovion) today announced the nationwide availability of ZETONNA™ (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known ...

Review the side-effects of Ciclesonide as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

ZUG, Switzerland, April 15, 2021 (GLOBE NEWSWIRE) -- Covis Pharma Group (the “Company”), a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening ...

- Sepracor acquires exclusive development, marketing and commercialisation rights to the Ciclesonide franchise in the United States - Ciclesonide is the active ingredient in the ALVESCO® Inhalation ...

Since then, asthma therapy guidelines have not changed much. The majority of asthma patients are still treated with a combination of ICS and short- or long-acting bronchodilators. Asthma guidelines ...

November 22, 2011 (Boston, Massachusetts) — The nasal corticosteroid spray ciclesonide is more effective than a broad-spectrum oral antibiotic for the treatment of children with otitis media with ...

The Global Ciclesonide Market, by Indication (Allergic Rhinitis and Asthma), by Dosage Form (Nasal Spray and Aerosol), and by Region (North America, Asia Pacific, Latin America, Europe, Middle East, ...

Patients Taking ZETONNA Report Improved Quality Of Life Measures (RQLQ[S]) Associated With Seasonal Allergic Rhinitis MARLBOROUGH, Mass., Jul 30, 2012 (BUSINESS WIRE) -- Sunovion Pharmaceuticals Inc. ...